DarioHealth Past Earnings Performance
Past criteria checks 0/6
DarioHealth's earnings have been declining at an average annual rate of -25.1%, while the Healthcare Services industry saw earnings growing at 2.8% annually. Revenues have been growing at an average rate of 31.2% per year.
Key information
-25.1%
Earnings growth rate
40.4%
EPS growth rate
| Healthcare Services Industry Growth | 1.7% |
| Revenue growth rate | 31.2% |
| Return on equity | -102.2% |
| Net Margin | -269.6% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
DarioHealth Corp. (NASDAQ:DRIO) Shares Could Be 23% Below Their Intrinsic Value Estimate
Feb 16
Time To Worry? Analysts Just Downgraded Their DarioHealth Corp. (NASDAQ:DRIO) Outlook
Nov 06Is DarioHealth (NASDAQ:DRIO) Using Debt Sensibly?
Oct 07Market Cool On DarioHealth Corp.'s (NASDAQ:DRIO) Revenues Pushing Shares 28% Lower
Aug 16Need To Know: Analysts Just Made A Substantial Cut To Their DarioHealth Corp. (NASDAQ:DRIO) Estimates
Aug 15DarioHealth Corp. (NASDAQ:DRIO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Aug 13DarioHealth (NASDAQ:DRIO) Is Using Debt Safely
Oct 05Need To Know: The Consensus Just Cut Its DarioHealth Corp. (NASDAQ:DRIO) Estimates For 2022
Aug 24DarioHealth Q2 2022 Earnings Preview
Aug 12DarioHealth: Paying 1.6x Equity Value For Cash Flows Priced Into The Future
Jul 29At US$8.95, Is It Time To Put DarioHealth Corp. (NASDAQ:DRIO) On Your Watch List?
Feb 11DarioHealth: Moving Towards An Inflection Point
Nov 30DarioHealth to be a part of Russell 2000 and 3000 Indexes
Jun 15We Think DarioHealth (NASDAQ:DRIO) Can Afford To Drive Business Growth
Jun 07Revenue & Expenses BreakdownBeta
How DarioHealth makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 20 | -55 | 42 | 20 |
| 30 Sep 23 | 24 | -57 | 39 | 21 |
| 30 Jun 23 | 27 | -58 | 40 | 20 |
| 31 Mar 23 | 27 | -58 | 43 | 19 |
| 31 Dec 22 | 28 | -60 | 47 | 20 |
| 30 Sep 22 | 27 | -65 | 57 | 20 |
| 30 Jun 22 | 26 | -73 | 63 | 21 |
| 31 Mar 22 | 25 | -72 | 64 | 20 |
| 31 Dec 21 | 21 | -68 | 62 | 17 |
| 30 Sep 21 | 17 | -58 | 54 | 13 |
| 30 Jun 21 | 13 | -43 | 42 | 9 |
| 31 Mar 21 | 10 | -32 | 31 | 6 |
| 31 Dec 20 | 8 | -33 | 28 | 4 |
| 30 Sep 20 | 7 | -31 | 24 | 4 |
| 30 Jun 20 | 7 | -26 | 21 | 4 |
| 31 Mar 20 | 7 | -27 | 21 | 4 |
| 31 Dec 19 | 8 | -21 | 17 | 4 |
| 30 Sep 19 | 7 | -19 | 17 | 4 |
| 30 Jun 19 | 7 | -20 | 17 | 4 |
| 31 Mar 19 | 8 | -21 | 18 | 4 |
| 31 Dec 18 | 7 | -18 | 16 | 4 |
| 30 Sep 18 | 7 | -17 | 14 | 4 |
| 30 Jun 18 | 7 | -16 | 13 | 3 |
| 31 Mar 18 | 6 | -14 | 11 | 4 |
| 31 Dec 17 | 5 | -16 | 12 | 3 |
| 30 Sep 17 | 4 | -16 | 12 | 3 |
| 30 Jun 17 | 4 | -14 | 12 | 3 |
| 31 Mar 17 | 3 | -14 | 11 | 2 |
| 31 Dec 16 | 3 | -12 | 8 | 2 |
| 30 Sep 16 | 2 | -9 | 7 | 2 |
| 30 Jun 16 | 2 | -10 | 6 | 2 |
| 31 Mar 16 | 1 | -8 | 5 | 2 |
| 31 Dec 15 | 1 | -7 | 4 | 3 |
| 30 Sep 15 | 1 | -9 | 4 | 3 |
| 30 Jun 15 | 0 | -14 | 3 | 3 |
| 31 Mar 15 | 0 | -15 | 4 | 4 |
| 31 Dec 14 | 0 | -16 | 5 | 4 |
| 30 Sep 14 | 0 | -13 | 6 | 5 |
| 30 Jun 14 | 0 | -10 | 7 | 5 |
| 31 Mar 14 | 0 | -12 | 7 | 5 |
| 31 Dec 13 | 0 | -14 | 9 | 5 |
| 30 Sep 13 | 0 | -15 | 8 | 4 |
Quality Earnings: DRIO is currently unprofitable.
Growing Profit Margin: DRIO is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DRIO is unprofitable, and losses have increased over the past 5 years at a rate of 25.1% per year.
Accelerating Growth: Unable to compare DRIO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: DRIO is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (15.4%).
Return on Equity
High ROE: DRIO has a negative Return on Equity (-102.21%), as it is currently unprofitable.